{
    "root": "629d74b1-3f70-4fd1-b849-7b273e7e2acb",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Neurontin",
    "value": "20250415",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "POLOXAMER 407",
            "code": "TUF2IVW3M2"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "CANDELILLA WAX",
            "code": "WL0328HX19"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "XYLITOL",
            "code": "VCQ006KQ1E"
        }
    ],
    "indications": "neurontin® indicated : •management postherpetic neuralgia adults •adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
    "contraindications": "• postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) • epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days • dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "neurontin ( gabapentin ) capsules , tablets , oral solution supplied follows : 100 mg capsules : white hard gelatin capsules printed “ vle ” body “ neurontin/100 mg ” cap ; available : bottles 100 : ndc 58151-281-01 300 mg capsules : yellow hard gelatin capsules printed “ vle ” body “ neurontin/300 mg ” cap ; available : bottles 100 : ndc 58151-282-01 400 mg capsules : orange hard gelatin capsules printed “ vle ” body “ neurontin/400 mg ” cap ; available : bottles 100 : ndc 58151-283-01 600 mg tablets : white elliptical film-coated scored tablets debossed “ nt ” “ 16 ” one side ; available : bottles 100 : ndc 58151-284-01 800 mg tablets : white elliptical film-coated scored tablets debossed “ nt ” “ 26 ” one side ; available : bottles 100 : ndc 58151-285-01 250 mg per 5 ml oral solution : clear colorless slightly yellow solution ; 5 ml oral solution contains 250 mg gabapentin ; available : bottles containing 470 ml : ndc 58151-290-35 store neurontin tablets capsules 25°c ( 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . store neurontin oral solution refrigerated , 2°c 8°c ( 36°f 46°f ) .",
    "adverseReactions": "neurontin contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "NEURONTIN® is indicated for:\n                  \n                     \n                        •Management of postherpetic neuralgia in adults\n                     \n                        •Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "• Postherpetic Neuralgia ( 2.1 ) o Dose can be titrated up as needed to a dose of 1800 mg/day o Day 1: Single 300 mg dose o Day 2: 600 mg/day (i.e., 300 mg two times a day) o Day 3: 900 mg/day (i.e., 300 mg three times a day) • Epilepsy with Partial Onset Seizures ( 2.2 ) o Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily o Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days • Dose should be adjusted in patients with reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions_original": "NEURONTIN (gabapentin) capsules, tablets, and oral solution are supplied as follows:\n                  100 mg capsules: \n                  White hard gelatin capsules printed with “VLE” on the body and “Neurontin/100 mg” on the cap; available in:Bottles of 100: NDC 58151-281-01\n                  300 mg capsules:\n                  Yellow hard gelatin capsules printed with “VLE” on the body and “Neurontin/300 mg” on the cap; available in:Bottles of 100: NDC 58151-282-01\n                  400 mg capsules:\n                  Orange hard gelatin capsules printed with “VLE” on the body and “Neurontin/400 mg” on the cap; available in:Bottles of 100: NDC 58151-283-01\n                  600 mg tablets:\n                  White elliptical film-coated scored tablets debossed with “NT” and “16” on one side; available in:Bottles of 100: NDC 58151-284-01\n                  800 mg tablets:\n                  White elliptical film-coated scored tablets debossed with “NT” and “26” on one side; available in:Bottles of 100: NDC 58151-285-01\n                  250 mg per 5 mL oral solution:\n                  Clear colorless to slightly yellow solution; each 5 mL of oral solution contains 250 mg of gabapentin; available in:Bottles containing 470 mL: NDC 58151-290-35\n                  Store NEURONTIN Tablets and Capsules at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  Store NEURONTIN Oral Solution refrigerated, 2°C to 8°C (36°F to 46°F).",
    "adverseReactions_original": "NEURONTIN is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}